Early nasopharyngeal carcinoma among IgA/VCA antibody positive individuals detected by anticomplement immunoenzymatic method.
D000328:Adult; D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D002277:Carcinoma / Q000175:diagnosis*; D002467:Cell Nucleus / Q000276:immunology; D003169:Complement Inactivator Proteins / Q000097:blood; D019309:Epstein-Barr Virus Nuclear Antigens; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D007070:Immunoglobulin A / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis*; D014412:Tumor Virus Infections / Q000175:diagnosis*
D000956:Antigens, Viral; D003169:Complement Inactivator Proteins; D019309:Epstein-Barr Virus Nuclear Antigens; D007070:Immunoglobulin A; C012749:anticomplement